The activist says he has recently purchased a large stake in Allergan, which in April called off its $150 billion pact with Pfizer.

Jim Cramer says the antitrust environment out there will make it difficult for any railroad mergers to be approved by regulators.

Investors are gearing up for another assessment of the global economy, as the Fed Prepares to release the minutes of its March meeting.

The latest rules are seen likely to prompt a rethink of the $150 billion pharmaceuticals deal.

Jim Cramer says the merger between Pfizer and Allergan isn't going anywhere, as lawmakers try to limit corporate inversions.

TheStreet's Jim Cramer said Valeant Pharmaceuticals' (VRX) move to appoint billionaire investor Bill Ackman to the board of directors isn't enough and a government monitor is needed.

Despite the financial hardships plaguing some economies, healthcare M&A is still on the rise and experts indicate there is no sign of it slowing.

TheStreet highlights 3 stocks pushing the drugs industry higher today.

The Botox maker now has complete 'facial domination,' Cramer says.

The 14-week decline in gasoline prices ended while two million people in Florida are still without power.

A new EV would radically change how cars are made and that could be a threat to the market leader.

The fast-food giant rarely tweaks its morning menu, but it's making two big additions as potentially an answer to a huge Wendy's move.